ERNA vs PFE · P/E 0.0, rev $582.0K vs P/E 20, rev $62.58B
Eterna Therapeutics Inc (ERNA) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the ERNA and PFE stock pages for the full models.
Not investment advice.